
Penumbra, Inc.
PEN
Updated: 23/09/2026, 09:37:45
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
No summaries found.
- Share price
- $319.39
- Market cap
- $12.58B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Adam Elsesser
- Employees
- 4,700
- IPO date
- 18/09/2015
- Beta
- 0.698
- Last dividend
- $0.00
- Day range
- $318.49 – $319.80
- 52-week range
- $221.26 – $362.41
- 1-day performance
- 0.19%
- 1-year performance
- 44.35%
- Current drawdown (1Y)
- -11.87%
- CIK
- 0001321732
- CUSIP
- 70975L107
- ISIN
- US70975L1070
- Created
- 07/12/2025, 05:43:26
- Last update
- 23/09/2026, 09:37:45
Track Penumbra, Inc. with an AI analyst
See which prediction-market events move PEN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
PRNewsWire • STOCK • 11/06/2026, 18:05:00
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
Zacks Investment Research • STOCK • 27/04/2026, 15:45:44
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
Zacks Investment Research • STOCK • 10/04/2026, 15:45:25
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Business Wire • STOCK • 08/04/2026, 00:04:00
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Zacks Investment Research • STOCK • 27/03/2026, 10:51:14
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks Investment Research • STOCK • 17/03/2026, 14:45:28
PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
Zacks Investment Research • STOCK • 02/03/2026, 09:46:09
Penumbra, Inc. (NYSE:PEN) Showcases Strong Financial Performance and Growth Potential
Market Data • Market Data • 26/02/2026, 20:10:04
Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research • STOCK • 25/02/2026, 18:30:20
Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
Zacks Investment Research • STOCK • 25/02/2026, 18:15:24